Late-Breaking Data Showcase the Benefits of Abbott's Minimal

New data presented at Transcatheter Cardiovascular Therapeutics 2023 from the TRILUMINATE™ pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid...

Related Keywords

Canada , Michael Dale , David Adams , Linkedin , Mount Sinai Health System , York Heart Association , Facebook , Icahn School Of Medicine At Mount Sinai , Cardiovascular Research Foundation , Transcatheter Cardiovascular Therapeutics , Cardiovascular Interventions , San Francisco , Kansas City Cardiomyopathy Questionnaire , Icahn School , Mount Sinai , One Year Results From , New York Heart Association , Functional Class , Markets ,